Similarly, in another study, they treated cell lines of different types of cancer [Hep-3B (liver), AGS (gastric), SiHa (cervical), MCF7 (breast), NTUB1 (bladder), and H460 (lung-non-small cells)] with different chemotherapy regimens (doxorubicin, 5-fluorouracil [5-FU], cisplatin, and paclitaxel), and found a correlation between cell survival with the level of drug-induced NF-κB activity (Chuang et al., 2002). Here, NFKB1 is linked to cancer.